Our understanding of the cell membrane has rapidly changed in recent years with improved technologies providing better insight into the organization and structure of various components and domains that form an integral part of the membrane. Efforts are now underway to selectively identify and target membrane domains, particularly membrane proteins, to disrupt their structural integrity or function, thereby leading to the desired downstream effects in the cell. However, membrane proteins are yet to be fully exploited as drug targets, partly because they are very difficult to express and work with. Cambridge Healthtech Institute’s second annual conference on Targeting Membrane Proteins brings together experts from all areas of drug discovery and translational research to talk about ways in which different classes of membrane proteins can be explored as drug targets for new therapeutic indications. Scientists from pharma/biotech, as well as from academic and government labs, will share their findings on which membrane proteins have been targeted effectively, how they have been screened and characterized, and what therapeutic applications are being looked at.
Who should attend: Students, Post-docs, Lab Technicians, Managers, Scientists, Clinicians, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Drug Discovery, Target Identification and Validation, Functional/High-throughput Screening, Assay Development and Translational Research.
Topics will include, but are not limited to:
- Evaluating tools to screen, characterize, express and quantify membrane proteins
- Setting up high-throughput technologies and phenotypic screens for membrane target identification
- Exploring new membrane targets for diverse therapeutic applications
- Studying known targets (GPCRs, ion channels, transporters) for new therapeutic indications, namely oncology
- Exploring tetraspanins, PD-L1 and other emerging membrane targets for oncology
- Using novel biological entities, nanobodies and more to selectively target membrane proteins
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for submission is November 9, 2015.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For questions or suggestions about the meeting, please contact:
Tanuja Koppal, Ph.D.
Cambridge Healthtech Institute
T: (+1) 973-525-4667
For sponsorship and exhibit sales information including sponsored podium presentations, contact:
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431